Quantity: 1 G
Product name: Semaglutide
Synonyms: NN 9535;NN9535;NNC 0113-0217;UNII-53AXN4NNHX;
CAS NO.: 910463-68-2
Counter ion: Acetate
Format: Lyophilized powder
Description: Semaglutide is a once-daily -like peptide-1 analog that differs to others by the presence of an acyl group with a steric diacid at Lys26 and a large synthetic spacer and modified by the presence of a α-aminobutyric acid in position 8 which gives stability against the dipeptidylpeptidase-4.1 The stability of semaglutide by the acylation permits a high-affinity albumin binding and gives it a long plasma half-life which allows the once-daily dosage. It was developed by the Danish pharmaceutical company Novo Nordisk and FDA approved on December 5, 2017.6
Usage: For Scientific Research Use Only, Not for Human Use.